-
1
-
-
0001086027
-
-
Arcamone, F.; Penco, S.; Orezzi, P. G.; Nicolella, V.; Pirelli, A. Nature 1964, 203, 1064.
-
(1964)
Nature
, vol.203
, pp. 1064
-
-
Arcamone, F.1
Penco, S.2
Orezzi, P.G.3
Nicolella, V.4
Pirelli, A.5
-
2
-
-
0021959842
-
-
Kopka, M. L.; Yoon, C.; Goodsell, D.; Pjura, P.; Dickerson, R. E. Proc. Natl. Acad. Sci. U.S.A. 1985, 82, 1376.
-
(1985)
Proc. Natl. Acad. Sci. U.S.A.
, vol.82
, pp. 1376
-
-
Kopka, M.L.1
Yoon, C.2
Goodsell, D.3
Pjura, P.4
Dickerson, R.E.5
-
5
-
-
0034608544
-
-
For recent examples, see α-Haloacylamides: (a) Cozzi, P.; Beria, I.; Caldarelli, M.; Capolongo, L.; Geroni, C.; Mongelli, N. Bioorg. Med. Chem. Lett. 2000, 10, 1269. (b) Cozzi, P. Farmaco 2001, 56, 57. (c) Cozzi, P.; Mongelli, N. Curr. Pharm. Des. 1998, 4, 181. (d) Krowicki, K.; Balzarini, J.; De Clerq, E.; Newman, R. A.; Lown, J. W. J. Med. Chem. 1988, 31, 341. (e) Baker, B. F.; Dervan, P. B. J. Am. Chem. Soc. 1985, 107, 8266. Nitrogen mustards: (f) Wang, Y.; Wright, S. C.; Larrick, J. W. Bioorg. Med. Chem. Lett. 2003, 13, 459. (g) Baraldi, P, G.; Romagnoli, R.; Guadix, A. E.; Pineda de la Infantas, M. J.; Gallo, M. A.; Espinosa, A.; Martinez, A.; Bingham, J. P.; Hartley, J. A. J. Med. Chem. 2002, 45, 3630. (h) Cozzi, P. C.; Beria, I.; Caldarelli, M.; Capolongo, L.; Geroni, C.; Mazzini, S.; Ragg, E. Bioorg. Med. Chem. Lett. 2000, 10, 1653. (i) Xie, G.; Gupta, R.; Lown, J. W. Anti-Cancer Drug Des. 1995, 10, 389. (j) Sigurdsson, S. T.; Rink, S. M.; Hopkins, P. B. J. Am. Chem. Soc. 1993, 115, 12633. (k) Sondhi, S. M.; Praveen-Reddy, B. S.; Lown, J. W. Curr. Med. Chem. 1997, 4, 313.
-
(2000)
Bioorg. Med. Chem. Lett.
, vol.10
, pp. 1269
-
-
Cozzi, P.1
Beria, I.2
Caldarelli, M.3
Capolongo, L.4
Geroni, C.5
Mongelli, N.6
-
6
-
-
0035272741
-
-
For recent examples, see α-Haloacylamides: (a) Cozzi, P.; Beria, I.; Caldarelli, M.; Capolongo, L.; Geroni, C.; Mongelli, N. Bioorg. Med. Chem. Lett. 2000, 10, 1269. (b) Cozzi, P. Farmaco 2001, 56, 57. (c) Cozzi, P.; Mongelli, N. Curr. Pharm. Des. 1998, 4, 181. (d) Krowicki, K.; Balzarini, J.; De Clerq, E.; Newman, R. A.; Lown, J. W. J. Med. Chem. 1988, 31, 341. (e) Baker, B. F.; Dervan, P. B. J. Am. Chem. Soc. 1985, 107, 8266. Nitrogen mustards: (f) Wang, Y.; Wright, S. C.; Larrick, J. W. Bioorg. Med. Chem. Lett. 2003, 13, 459. (g) Baraldi, P, G.; Romagnoli, R.; Guadix, A. E.; Pineda de la Infantas, M. J.; Gallo, M. A.; Espinosa, A.; Martinez, A.; Bingham, J. P.; Hartley, J. A. J. Med. Chem. 2002, 45, 3630. (h) Cozzi, P. C.; Beria, I.; Caldarelli, M.; Capolongo, L.; Geroni, C.; Mazzini, S.; Ragg, E. Bioorg. Med. Chem. Lett. 2000, 10, 1653. (i) Xie, G.; Gupta, R.; Lown, J. W. Anti-Cancer Drug Des. 1995, 10, 389. (j) Sigurdsson, S. T.; Rink, S. M.; Hopkins, P. B. J. Am. Chem. Soc. 1993, 115, 12633. (k) Sondhi, S. M.; Praveen-Reddy, B. S.; Lown, J. W. Curr. Med. Chem. 1997, 4, 313.
-
(2001)
Farmaco
, vol.56
, pp. 57
-
-
Cozzi, P.1
-
7
-
-
0031836173
-
-
For recent examples, see α-Haloacylamides: (a) Cozzi, P.; Beria, I.; Caldarelli, M.; Capolongo, L.; Geroni, C.; Mongelli, N. Bioorg. Med. Chem. Lett. 2000, 10, 1269. (b) Cozzi, P. Farmaco 2001, 56, 57. (c) Cozzi, P.; Mongelli, N. Curr. Pharm. Des. 1998, 4, 181. (d) Krowicki, K.; Balzarini, J.; De Clerq, E.; Newman, R. A.; Lown, J. W. J. Med. Chem. 1988, 31, 341. (e) Baker, B. F.; Dervan, P. B. J. Am. Chem. Soc. 1985, 107, 8266. Nitrogen mustards: (f) Wang, Y.; Wright, S. C.; Larrick, J. W. Bioorg. Med. Chem. Lett. 2003, 13, 459. (g) Baraldi, P, G.; Romagnoli, R.; Guadix, A. E.; Pineda de la Infantas, M. J.; Gallo, M. A.; Espinosa, A.; Martinez, A.; Bingham, J. P.; Hartley, J. A. J. Med. Chem. 2002, 45, 3630. (h) Cozzi, P. C.; Beria, I.; Caldarelli, M.; Capolongo, L.; Geroni, C.; Mazzini, S.; Ragg, E. Bioorg. Med. Chem. Lett. 2000, 10, 1653. (i) Xie, G.; Gupta, R.; Lown, J. W. Anti-Cancer Drug Des. 1995, 10, 389. (j) Sigurdsson, S. T.; Rink, S. M.; Hopkins, P. B. J. Am. Chem. Soc. 1993, 115, 12633. (k) Sondhi, S. M.; Praveen-Reddy, B. S.; Lown, J. W. Curr. Med. Chem. 1997, 4, 313.
-
(1998)
Curr. Pharm. Des.
, vol.4
, pp. 181
-
-
Cozzi, P.1
Mongelli, N.2
-
8
-
-
0006828126
-
-
For recent examples, see α-Haloacylamides: (a) Cozzi, P.; Beria, I.; Caldarelli, M.; Capolongo, L.; Geroni, C.; Mongelli, N. Bioorg. Med. Chem. Lett. 2000, 10, 1269. (b) Cozzi, P. Farmaco 2001, 56, 57. (c) Cozzi, P.; Mongelli, N. Curr. Pharm. Des. 1998, 4, 181. (d) Krowicki, K.; Balzarini, J.; De Clerq, E.; Newman, R. A.; Lown, J. W. J. Med. Chem. 1988, 31, 341. (e) Baker, B. F.; Dervan, P. B. J. Am. Chem. Soc. 1985, 107, 8266. Nitrogen mustards: (f) Wang, Y.; Wright, S. C.; Larrick, J. W. Bioorg. Med. Chem. Lett. 2003, 13, 459. (g) Baraldi, P, G.; Romagnoli, R.; Guadix, A. E.; Pineda de la Infantas, M. J.; Gallo, M. A.; Espinosa, A.; Martinez, A.; Bingham, J. P.; Hartley, J. A. J. Med. Chem. 2002, 45, 3630. (h) Cozzi, P. C.; Beria, I.; Caldarelli, M.; Capolongo, L.; Geroni, C.; Mazzini, S.; Ragg, E. Bioorg. Med. Chem. Lett. 2000, 10, 1653. (i) Xie, G.; Gupta, R.; Lown, J. W. Anti-Cancer Drug Des. 1995, 10, 389. (j) Sigurdsson, S. T.; Rink, S. M.; Hopkins, P. B. J. Am. Chem. Soc. 1993, 115, 12633. (k) Sondhi, S. M.; Praveen-Reddy, B. S.; Lown, J. W. Curr. Med. Chem. 1997, 4, 313.
-
(1988)
J. Med. Chem.
, vol.31
, pp. 341
-
-
Krowicki, K.1
Balzarini, J.2
De Clerq, E.3
Newman, R.A.4
Lown, J.W.5
-
9
-
-
0022408319
-
-
For recent examples, see α-Haloacylamides: (a) Cozzi, P.; Beria, I.; Caldarelli, M.; Capolongo, L.; Geroni, C.; Mongelli, N. Bioorg. Med. Chem. Lett. 2000, 10, 1269. (b) Cozzi, P. Farmaco 2001, 56, 57. (c) Cozzi, P.; Mongelli, N. Curr. Pharm. Des. 1998, 4, 181. (d) Krowicki, K.; Balzarini, J.; De Clerq, E.; Newman, R. A.; Lown, J. W. J. Med. Chem. 1988, 31, 341. (e) Baker, B. F.; Dervan, P. B. J. Am. Chem. Soc. 1985, 107, 8266. Nitrogen mustards: (f) Wang, Y.; Wright, S. C.; Larrick, J. W. Bioorg. Med. Chem. Lett. 2003, 13, 459. (g) Baraldi, P, G.; Romagnoli, R.; Guadix, A. E.; Pineda de la Infantas, M. J.; Gallo, M. A.; Espinosa, A.; Martinez, A.; Bingham, J. P.; Hartley, J. A. J. Med. Chem. 2002, 45, 3630. (h) Cozzi, P. C.; Beria, I.; Caldarelli, M.; Capolongo, L.; Geroni, C.; Mazzini, S.; Ragg, E. Bioorg. Med. Chem. Lett. 2000, 10, 1653. (i) Xie, G.; Gupta, R.; Lown, J. W. Anti-Cancer Drug Des. 1995, 10, 389. (j) Sigurdsson, S. T.; Rink, S. M.; Hopkins, P. B. J. Am. Chem. Soc. 1993, 115, 12633. (k) Sondhi, S. M.; Praveen-Reddy, B. S.; Lown, J. W. Curr. Med. Chem. 1997, 4, 313.
-
(1985)
J. Am. Chem. Soc.
, vol.107
, pp. 8266
-
-
Baker, B.F.1
Dervan, P.B.2
-
10
-
-
0037325518
-
-
For recent examples, see α-Haloacylamides: (a) Cozzi, P.; Beria, I.; Caldarelli, M.; Capolongo, L.; Geroni, C.; Mongelli, N. Bioorg. Med. Chem. Lett. 2000, 10, 1269. (b) Cozzi, P. Farmaco 2001, 56, 57. (c) Cozzi, P.; Mongelli, N. Curr. Pharm. Des. 1998, 4, 181. (d) Krowicki, K.; Balzarini, J.; De Clerq, E.; Newman, R. A.; Lown, J. W. J. Med. Chem. 1988, 31, 341. (e) Baker, B. F.; Dervan, P. B. J. Am. Chem. Soc. 1985, 107, 8266. Nitrogen mustards: (f) Wang, Y.; Wright, S. C.; Larrick, J. W. Bioorg. Med. Chem. Lett. 2003, 13, 459. (g) Baraldi, P, G.; Romagnoli, R.; Guadix, A. E.; Pineda de la Infantas, M. J.; Gallo, M. A.; Espinosa, A.; Martinez, A.; Bingham, J. P.; Hartley, J. A. J. Med. Chem. 2002, 45, 3630. (h) Cozzi, P. C.; Beria, I.; Caldarelli, M.; Capolongo, L.; Geroni, C.; Mazzini, S.; Ragg, E. Bioorg. Med. Chem. Lett. 2000, 10, 1653. (i) Xie, G.; Gupta, R.; Lown, J. W. Anti-Cancer Drug Des. 1995, 10, 389. (j) Sigurdsson, S. T.; Rink, S. M.; Hopkins, P. B. J. Am. Chem. Soc. 1993, 115, 12633. (k) Sondhi, S. M.; Praveen-Reddy, B. S.; Lown, J. W. Curr. Med. Chem. 1997, 4, 313.
-
(2003)
Bioorg. Med. Chem. Lett.
, vol.13
, pp. 459
-
-
Wang, Y.1
Wright, S.C.2
Larrick, J.W.3
-
11
-
-
0037103228
-
-
For recent examples, see α-Haloacylamides: (a) Cozzi, P.; Beria, I.; Caldarelli, M.; Capolongo, L.; Geroni, C.; Mongelli, N. Bioorg. Med. Chem. Lett. 2000, 10, 1269. (b) Cozzi, P. Farmaco 2001, 56, 57. (c) Cozzi, P.; Mongelli, N. Curr. Pharm. Des. 1998, 4, 181. (d) Krowicki, K.; Balzarini, J.; De Clerq, E.; Newman, R. A.; Lown, J. W. J. Med. Chem. 1988, 31, 341. (e) Baker, B. F.; Dervan, P. B. J. Am. Chem. Soc. 1985, 107, 8266. Nitrogen mustards: (f) Wang, Y.; Wright, S. C.; Larrick, J. W. Bioorg. Med. Chem. Lett. 2003, 13, 459. (g) Baraldi, P, G.; Romagnoli, R.; Guadix, A. E.; Pineda de la Infantas, M. J.; Gallo, M. A.; Espinosa, A.; Martinez, A.; Bingham, J. P.; Hartley, J. A. J. Med. Chem. 2002, 45, 3630. (h) Cozzi, P. C.; Beria, I.; Caldarelli, M.; Capolongo, L.; Geroni, C.; Mazzini, S.; Ragg, E. Bioorg. Med. Chem. Lett. 2000, 10, 1653. (i) Xie, G.; Gupta, R.; Lown, J. W. Anti-Cancer Drug Des. 1995, 10, 389. (j) Sigurdsson, S. T.; Rink, S. M.; Hopkins, P. B. J. Am. Chem. Soc. 1993, 115, 12633. (k) Sondhi, S. M.; Praveen-Reddy, B. S.; Lown, J. W. Curr. Med. Chem. 1997, 4, 313.
-
(2002)
J. Med. Chem.
, vol.45
, pp. 3630
-
-
Baraldi, P.G.1
Romagnoli, R.2
Guadix, A.E.3
Pineda de la Infantas, M.J.4
Gallo, M.A.5
Espinosa, A.6
Martinez, A.7
Bingham, J.P.8
Hartley, J.A.9
-
12
-
-
0034618237
-
-
For recent examples, see α-Haloacylamides: (a) Cozzi, P.; Beria, I.; Caldarelli, M.; Capolongo, L.; Geroni, C.; Mongelli, N. Bioorg. Med. Chem. Lett. 2000, 10, 1269. (b) Cozzi, P. Farmaco 2001, 56, 57. (c) Cozzi, P.; Mongelli, N. Curr. Pharm. Des. 1998, 4, 181. (d) Krowicki, K.; Balzarini, J.; De Clerq, E.; Newman, R. A.; Lown, J. W. J. Med. Chem. 1988, 31, 341. (e) Baker, B. F.; Dervan, P. B. J. Am. Chem. Soc. 1985, 107, 8266. Nitrogen mustards: (f) Wang, Y.; Wright, S. C.; Larrick, J. W. Bioorg. Med. Chem. Lett. 2003, 13, 459. (g) Baraldi, P, G.; Romagnoli, R.; Guadix, A. E.; Pineda de la Infantas, M. J.; Gallo, M. A.; Espinosa, A.; Martinez, A.; Bingham, J. P.; Hartley, J. A. J. Med. Chem. 2002, 45, 3630. (h) Cozzi, P. C.; Beria, I.; Caldarelli, M.; Capolongo, L.; Geroni, C.; Mazzini, S.; Ragg, E. Bioorg. Med. Chem. Lett. 2000, 10, 1653. (i) Xie, G.; Gupta, R.; Lown, J. W. Anti-Cancer Drug Des. 1995, 10, 389. (j) Sigurdsson, S. T.; Rink, S. M.; Hopkins, P. B. J. Am. Chem. Soc. 1993, 115, 12633. (k) Sondhi, S. M.; Praveen-Reddy, B. S.; Lown, J. W. Curr. Med. Chem. 1997, 4, 313.
-
(2000)
Bioorg. Med. Chem. Lett.
, vol.10
, pp. 1653
-
-
Cozzi, P.C.1
Beria, I.2
Caldarelli, M.3
Capolongo, L.4
Geroni, C.5
Mazzini, S.6
Ragg, E.7
-
13
-
-
0029087804
-
-
For recent examples, see α-Haloacylamides: (a) Cozzi, P.; Beria, I.; Caldarelli, M.; Capolongo, L.; Geroni, C.; Mongelli, N. Bioorg. Med. Chem. Lett. 2000, 10, 1269. (b) Cozzi, P. Farmaco 2001, 56, 57. (c) Cozzi, P.; Mongelli, N. Curr. Pharm. Des. 1998, 4, 181. (d) Krowicki, K.; Balzarini, J.; De Clerq, E.; Newman, R. A.; Lown, J. W. J. Med. Chem. 1988, 31, 341. (e) Baker, B. F.; Dervan, P. B. J. Am. Chem. Soc. 1985, 107, 8266. Nitrogen mustards: (f) Wang, Y.; Wright, S. C.; Larrick, J. W. Bioorg. Med. Chem. Lett. 2003, 13, 459. (g) Baraldi, P, G.; Romagnoli, R.; Guadix, A. E.; Pineda de la Infantas, M. J.; Gallo, M. A.; Espinosa, A.; Martinez, A.; Bingham, J. P.; Hartley, J. A. J. Med. Chem. 2002, 45, 3630. (h) Cozzi, P. C.; Beria, I.; Caldarelli, M.; Capolongo, L.; Geroni, C.; Mazzini, S.; Ragg, E. Bioorg. Med. Chem. Lett. 2000, 10, 1653. (i) Xie, G.; Gupta, R.; Lown, J. W. Anti-Cancer Drug Des. 1995, 10, 389. (j) Sigurdsson, S. T.; Rink, S. M.; Hopkins, P. B. J. Am. Chem. Soc. 1993, 115, 12633. (k) Sondhi, S. M.; Praveen-Reddy, B. S.; Lown, J. W. Curr. Med. Chem. 1997, 4, 313.
-
(1995)
Anti- Cancer Drug Des.
, vol.10
, pp. 389
-
-
Xie, G.1
Gupta, R.2
Lown, J.W.3
-
14
-
-
0027882506
-
-
For recent examples, see α-Haloacylamides: (a) Cozzi, P.; Beria, I.; Caldarelli, M.; Capolongo, L.; Geroni, C.; Mongelli, N. Bioorg. Med. Chem. Lett. 2000, 10, 1269. (b) Cozzi, P. Farmaco 2001, 56, 57. (c) Cozzi, P.; Mongelli, N. Curr. Pharm. Des. 1998, 4, 181. (d) Krowicki, K.; Balzarini, J.; De Clerq, E.; Newman, R. A.; Lown, J. W. J. Med. Chem. 1988, 31, 341. (e) Baker, B. F.; Dervan, P. B. J. Am. Chem. Soc. 1985, 107, 8266. Nitrogen mustards: (f) Wang, Y.; Wright, S. C.; Larrick, J. W. Bioorg. Med. Chem. Lett. 2003, 13, 459. (g) Baraldi, P, G.; Romagnoli, R.; Guadix, A. E.; Pineda de la Infantas, M. J.; Gallo, M. A.; Espinosa, A.; Martinez, A.; Bingham, J. P.; Hartley, J. A. J. Med. Chem. 2002, 45, 3630. (h) Cozzi, P. C.; Beria, I.; Caldarelli, M.; Capolongo, L.; Geroni, C.; Mazzini, S.; Ragg, E. Bioorg. Med. Chem. Lett. 2000, 10, 1653. (i) Xie, G.; Gupta, R.; Lown, J. W. Anti-Cancer Drug Des. 1995, 10, 389. (j) Sigurdsson, S. T.; Rink, S. M.; Hopkins, P. B. J. Am. Chem. Soc. 1993, 115, 12633. (k) Sondhi, S. M.; Praveen-Reddy, B. S.; Lown, J. W. Curr. Med. Chem. 1997, 4, 313.
-
(1993)
J. Am. Chem. Soc.
, vol.115
, pp. 12633
-
-
Sigurdsson, S.T.1
Rink, S.M.2
Hopkins, P.B.3
-
15
-
-
9844251216
-
-
For recent examples, see α-Haloacylamides: (a) Cozzi, P.; Beria, I.; Caldarelli, M.; Capolongo, L.; Geroni, C.; Mongelli, N. Bioorg. Med. Chem. Lett. 2000, 10, 1269. (b) Cozzi, P. Farmaco 2001, 56, 57. (c) Cozzi, P.; Mongelli, N. Curr. Pharm. Des. 1998, 4, 181. (d) Krowicki, K.; Balzarini, J.; De Clerq, E.; Newman, R. A.; Lown, J. W. J. Med. Chem. 1988, 31, 341. (e) Baker, B. F.; Dervan, P. B. J. Am. Chem. Soc. 1985, 107, 8266. Nitrogen mustards: (f) Wang, Y.; Wright, S. C.; Larrick, J. W. Bioorg. Med. Chem. Lett. 2003, 13, 459. (g) Baraldi, P, G.; Romagnoli, R.; Guadix, A. E.; Pineda de la Infantas, M. J.; Gallo, M. A.; Espinosa, A.; Martinez, A.; Bingham, J. P.; Hartley, J. A. J. Med. Chem. 2002, 45, 3630. (h) Cozzi, P. C.; Beria, I.; Caldarelli, M.; Capolongo, L.; Geroni, C.; Mazzini, S.; Ragg, E. Bioorg. Med. Chem. Lett. 2000, 10, 1653. (i) Xie, G.; Gupta, R.; Lown, J. W. Anti-Cancer Drug Des. 1995, 10, 389. (j) Sigurdsson, S. T.; Rink, S. M.; Hopkins, P. B. J. Am. Chem. Soc. 1993, 115, 12633. (k) Sondhi, S. M.; Praveen-Reddy, B. S.; Lown, J. W. Curr. Med. Chem. 1997, 4, 313.
-
(1997)
Curr. Med. Chem.
, vol.4
, pp. 313
-
-
Sondhi, S.M.1
Praveen-Reddy, B.S.2
Lown, J.W.3
-
18
-
-
0032282321
-
-
(c) Jia, G. F.; lida, H.; Lown, J. W. Heterocycl. Commun. 1998, 4, 557.
-
(1998)
Heterocycl. Commun.
, vol.4
, pp. 557
-
-
Jia, G.F.1
Lida, H.2
Lown, J.W.3
-
21
-
-
0035812739
-
-
(f) Boger, D. L.; Schmitt, H.; Fink, B. E.; Hedrick, M. P. J. Org. Chem. 2001, 66, 6654.
-
(2001)
J. Org. Chem.
, vol.66
, pp. 6654
-
-
Boger, D.L.1
Schmitt, H.2
Fink, B.E.3
Hedrick, M.P.4
-
22
-
-
0033105645
-
-
Tao, Z.-H.; Fujiwara, T.; Saito, I.; Sugiyama, H. Angew. Chem., Int. Ed. 1999, 38, 650.
-
(1999)
Angew. Chem. Int. Ed.
, vol.38
, pp. 650
-
-
Tao, Z.-H.1
Fujiwara, T.2
Saito, I.3
Sugiyama, H.4
-
24
-
-
0038367555
-
-
Matsui, Y.; Kawabe, C.; Matsumoto, K.; Abe, K.; Miwa, T. Phytochemistry 1989, 25, 1470.
-
(1989)
Phytochemistry
, vol.25
, pp. 1470
-
-
Matsui, Y.1
Kawabe, C.2
Matsumoto, K.3
Abe, K.4
Miwa, T.5
-
25
-
-
0034641332
-
-
Boger, D. L.; Fink, B. E.; Hedrick, M. P. J. Am. Chem. Soc. 2000, 122, 6382.
-
(2000)
J. Am. Chem. Soc.
, vol.122
, pp. 6382
-
-
Boger, D.L.1
Fink, B.E.2
Hedrick, M.P.3
-
26
-
-
45449097286
-
-
For reviews: (a) Boger, D. L. Tetrahedron 1983, 39, 2869.
-
(1983)
Tetrahedron
, vol.39
, pp. 2869
-
-
Boger, D.L.1
-
31
-
-
0347152635
-
-
Boger, D. L.; Coleman, R. S.; Panek, J. S.; Huber, F. X.; Sauer, J. J. Org. Chem, 1985, 50, 5377.
-
(1985)
J. Org. Chem.
, vol.50
, pp. 5377
-
-
Boger, D.L.1
Coleman, R.S.2
Panek, J.S.3
Huber, F.X.4
Sauer, J.5
-
32
-
-
33947482868
-
-
(a) Corey, E. J.; Bass, J. D.; LeMahieu, R.; Mitra, R. B. J. Am. Chem. Soc. 1964, 86, 5570.
-
(1964)
J. Am. Chem. Soc.
, vol.86
, pp. 5570
-
-
Corey, E.J.1
Bass, J.D.2
LeMahieu, R.3
Mitra, R.B.4
-
34
-
-
0001605417
-
-
(a) Boger, D. L.; Coleman, R. S.; Panek, J. S.; Yohannes, D. J. Org. Chem. 1984, 49, 4405.
-
(1984)
J. Org. Chem.
, vol.49
, pp. 4405
-
-
Boger, D.L.1
Coleman, R.S.2
Panek, J.S.3
Yohannes, D.4
-
37
-
-
4244183856
-
-
Bernasconi, C.; Cottier, L.; Descotes, G.; Nigay, H.; Pardon, J. C.; Wisniewski, A. Bull. Soc. Chim. Fr. 1984, 7, II-323.
-
(1984)
Bull. Soc. Chim. Fr.
, vol.7
-
-
Bernasconi, C.1
Cottier, L.2
Descotes, G.3
Nigay, H.4
Pardon, J.C.5
Wisniewski, A.6
-
38
-
-
0034833710
-
-
(a) Boger, D. L.; Fink, B. E.; Brunette, S. R.; Tse, W. C.; Hedrick, M. P. J. Am. Chem. Soc. 2001, 123, 5878.
-
(2001)
J. Am. Chem. Soc.
, vol.123
, pp. 5878
-
-
Boger, D.L.1
Fink, B.E.2
Brunette, S.R.3
Tse, W.C.4
Hedrick, M.P.5
-
40
-
-
0037691461
-
-
note
-
50 = 67 (1), 119 (3), 165 (4), >200 (5), and >200 μM (6).
-
-
-
-
41
-
-
0038367556
-
-
note
-
Concentration of resin-bound Rose Bengal was determined according to ref 15 (0.09 mol of Rose Bengal/g of support).
-
-
-
|